Commission on preliminary consideration of anti-doping rules violations of RAA RUSADA rendered the decision that made athlete Pavlov Dmitriy (bodybuilding) whose sample returned an Adverse Analytical Finding for drostanolone metabolite, dehydrochloromethyltestosterone metabolite, fluoxymesterone and its metabolite, trenbolone metabolite (class S1.1 of the 2026 WADA Prohibited List), SARMS LGD-4033 (ligandrol) and its metabolite, clenbuterole (class S1.2 of the 2026 WADA Prohibited List), hydrochlorotiazide and its metabolite, canrenone (class S5 of the 2026 WADA Prohibited List) ineligible for 6 years for violation under cl. 4.1 and cl. 4.2 of the All-Russian Anti-Doping Rules, starting on the date of the decision, namely June 16, 2026, with credit for the served period of provisional suspension, namely from April 16, 2026.
